Cantor Fitzgerald’s Zimmer Biomet ZBH Stock Holding History

Cantor Fitzgerald’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-160,648	Closed	-$18M	–	586
2023 Q3	$18M	Buy	160,648 +4,744	+3%	+$602K	0.48%	68
2023 Q2	$22.7M	Buy	155,904 +2,411	+2%	+$328K	0.52%	56
2023 Q1	$19.8M	Buy	+153,493	New	+$19.3M	0.42%	74

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cantor Fitzgerald's ZBH Position: Q4 2023 in Review

Cantor Fitzgerald sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 160,648 shares — an estimated $18M sold.

Cantor Fitzgerald first reported a position in ZBH in Q1 2023 and held it in 3 quarters. The position peaked at $22.7M in Q2 2023. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

Cantor Fitzgerald reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
Cantor Fitzgerald sold 160,648 Zimmer Biomet shares in Q4 2023, an estimated $18M.
Cantor Fitzgerald first reported a position in Zimmer Biomet in Q1 2023 and held it in 3 quarters.
Cantor Fitzgerald's Zimmer Biomet position peaked at $22.7M in Q2 2023.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.